Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)
CNY 37.71
(-1.33%)
CNY 37.71
(-1.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 932.12 Million | 676.6 Million | 493.64 Million | 347.35 Million | 233.52 Million | 134.79 Million |
| Cost of Revenue | 403.77 Million | 301.14 Million | 229.96 Million | 175.02 Million | 126.35 Million | 77.66 Million |
| Gross Profit | 528.34 Million | 375.45 Million | 263.68 Million | 172.33 Million | 107.16 Million | 57.13 Million |
| Operating Expenses | 334.18 Million | 185.59 Million | 128.86 Million | 86.32 Million | 54.12 Million | 28.72 Million |
| Selling, General and Administrative Expenses | 44.06 Million | 35.8 Million | 28.38 Million | 18.45 Million | 11.05 Million | 6.37 Million |
| Research and Development Expenses | 123.68 Million | 89.68 Million | 47.57 Million | 34.19 Million | 19.06 Million | 8.46 Million |
| Other Expenses | 166.44 Million | 60.11 Million | 52.9 Million | 33.68 Million | 23.99 Million | -349.92 Thousand |
| Cost and Expenses | 737.95 Million | 486.74 Million | 358.83 Million | 261.35 Million | 180.47 Million | 106.38 Million |
| Operating Income | 194.16 Million | 169.27 Million | 122.59 Million | 82.78 Million | 55.04 Million | 23.63 Million |
| Interest Expense | 12.17 Million | 9.69 Million | 3.56 Million | 1.04 Million | 750.78 Thousand | 2.07 Million |
| Income Tax Expense | 10.5 Million | 11.09 Million | 13.3 Million | 8.12 Million | 6.52 Million | 3.12 Million |
| Earnings before Tax | 193.39 Million | 169.13 Million | 122.1 Million | 82.28 Million | 54.45 Million | 23.28 Million |
| Net Income | 184.75 Million | 156.47 Million | 105.66 Million | 72.46 Million | 47.4 Million | 20.71 Million |
| Earnings Per Share Basic | 1.65 | 1.39 | 0.94 | 0.65 | 0.42 | 0.25 |
| Earnings Per Share Diluted | 1.65 | 1.39 | 0.94 | 0.65 | 0.42 | 0.25 |
| Weighted Average Shares Outstanding | 111.97 Million | 112 Million | 112 Million | 112 Million | 112 Million | 82.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 111.97 Million | 112 Million | 112 Million | 112 Million | 112 Million | 82.87 Million |
| Gross Margin | 0.57 | 0.55 | 0.53 | 0.50 | 0.46 | 0.42 |
| EBIT Margin | 0.27 | 0.35 | 0.33 | 0.28 | 0.26 | 0.26 |
| Profit Margin | 0.20 | 0.23 | 0.21 | 0.21 | 0.20 | 0.15 |
| EBITDA | 250.5 Million | 231.85 Million | 159.09 Million | 93.77 Million | 65.75 Million | 30.68 Million |
| Earnings Before Tax Margin | 0.21 | 0.25 | 0.25 | 0.24 | 0.24 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 353.2 Million | 310.32 Million | 252.26 Million | 932.12 Million | 240.11 Million | 230.95 Million |
| Cost of Revenue | 190.92 Million | 153.18 Million | 101.96 Million | 403.77 Million | 99.93 Million | 105.24 Million |
| Gross Profit | 162.27 Million | 157.14 Million | 150.29 Million | 528.34 Million | 140.17 Million | 125.71 Million |
| Operating Expenses | 94.43 Million | 73.73 Million | 60.97 Million | 270.3 Million | 97.42 Million | 61.01 Million |
| Selling, General and Administrative Expenses | 44.02 Million | 44.5 Million | 33.17 Million | - | -31.87 Million | 69.23 Million |
| Research and Development Expenses | 50.41 Million | 29.23 Million | 34.96 Million | - | 40.55 Million | 29.76 Million |
| Other Expenses | - | -1.4 Million | -120.79 Thousand | -764.51 Thousand | -273.24 Thousand | -429.2 Thousand |
| Cost and Expenses | 285.35 Million | 226.91 Million | 162.94 Million | 674.07 Million | 197.35 Million | 166.26 Million |
| Operating Income | 67.84 Million | 83.4 Million | 74.43 Million | 194.16 Million | 10.69 Million | 54.91 Million |
| Interest Expense | 3.78 Million | 4.22 Million | 4.12 Million | 12.17 Million | 3.92 Million | 3.03 Million |
| Income Tax Expense | 3.25 Million | 7.9 Million | 5.56 Million | 10.5 Million | 172.39 Thousand | 1.14 Million |
| Earnings before Tax | 65.7 Million | 80.5 Million | 74.31 Million | 193.39 Million | 10.41 Million | 54.48 Million |
| Net Income | 59.11 Million | 75.81 Million | 72.75 Million | 184.75 Million | 13.68 Million | 53.08 Million |
| Earnings Per Share Basic | 0.53 | 0.68 | 0.65 | - | 0.12 | 0.47 |
| Earnings Per Share Diluted | 0.53 | 0.68 | 0.65 | - | 0.12 | 0.47 |
| Weighted Average Shares Outstanding | 112 Million | 112 Million | 111.92 Million | 111.97 Million | 112.45 Million | 112 Million |
| Weighted Average Shares Outstanding (Diluted) | 112 Million | 112 Million | 111.92 Million | 111.97 Million | 112.45 Million | 112 Million |
| Gross Margin | 0.46 | 0.51 | 0.60 | 0.57 | 0.58 | 0.54 |
| EBIT Margin | 0.20 | 0.32 | 0.36 | - | 0.19 | 0.29 |
| Profit Margin | 0.17 | 0.24 | 0.29 | 0.20 | 0.06 | 0.23 |
| EBITDA | 69.49 Million | 100.1 Million | 91.52 Million | - | 45.58 Million | 66.21 Million |
| Earnings Before Tax Margin | 0.19 | 0.27 | 0.30 | 0.21 | 0.04 | 0.24 |
RDEMF
CUBI
300953
MGLLF
8338
NTPIF